Form: DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

June 1, 2018

EXHIBIT 21.1

SUBSIDIARIES OF SUTRO BIOPHARMA, INC.

None.